» Authors » Axel Gerdtsson

Axel Gerdtsson

Explore the profile of Axel Gerdtsson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 231
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bjartmar I, Gerdtsson A, Torbrand C, Kristiansen S
BJU Int . 2025 Feb; PMID: 39971595
Objectives: To examine the risk of progression and time to progression from penile intraepithelial neoplasia (PeIN) to invasive penile cancer in patients treated for PeIN with either surgery, laser ablation...
2.
Warnolf A, Glombik D, Sandin F, Lambe M, Baseckas G, Gerdtsson A, et al.
Scand J Urol . 2024 Oct; 59:162-168. PMID: 39356203
Objective: The National Penile Cancer Register (NPECR) in Sweden was initiated in year 2000 and currently contains more than 3,900 men diagnosed with penile cancer. The aim of this study...
3.
Thor A, Negaard H, Bergdahl A, Almas B, Larsen S, Lundgren P, et al.
Eur Urol Open Sci . 2024 Jul; 65:13-19. PMID: 38966804
Background And Objective: There is an unmet need to avoid long-term morbidity associated with standard cytotoxic treatment for low-volume metastatic seminoma. Our aim was to assess the oncological efficacy and...
4.
Patras I, Abrahamsson J, Gerdtsson A, Nyberg M, Saemundsson Y, Stahl E, et al.
Scand J Urol . 2024 Jun; 59:131-136. PMID: 38896113
Objective: Disease recurrence, particularly intravesical recurrence (IVR) after radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC), is common. We investigated whether violations of onco-surgical principles before or during RNU,...
5.
Gerdtsson A, Negaard H, Almas B, Bergdahl A, Cohn-Cedermark G, Glimelius I, et al.
BJU Int . 2024 Jan; 133(6):717-724. PMID: 38293778
Objectives: To assess whether extended surveillance with repeated computed tomography (CT) scans for patients with clinical stage IIA (CS IIA; <2 cm abdominal node involvement) and negative markers (Mk-) non-seminomatous...
6.
Bobjer J, Gerdtsson A, Abrahamsson J, Baseckas G, Bergkvist M, Blackberg M, et al.
Eur Urol Open Sci . 2023 Nov; 57:37-44. PMID: 38020529
Background: There is limited information on the distribution of retroperitoneal lymph node metastases (LNMs) in upper tract urothelial carcinoma (UTUC). Objective: To investigate the location of LNMs in UTUC of...
7.
Antonelli L, Ardizzone D, Tachibana I, Adra N, Cary C, Hugar L, et al.
J Clin Oncol . 2023 Sep; 41(34):5296-5305. PMID: 37656935
Purpose: No consensus exists on the management of men with nonseminoma and viable nonteratomatous germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection (pcRPLND) specimen after first-line chemotherapy. We...
8.
Gerdtsson A, Torisson G, Thor A, Bergdahl A, Almas B, Hakansson U, et al.
BJU Int . 2023 May; 132(3):329-336. PMID: 37129962
Objective: To validate Vergouwe's prediction model using the Swedish and Norwegian Testicular Cancer Group (SWENOTECA) RETROP database and to define its clinical utility. Materials And Methods: Vergouwe's prediction model for...
9.
Brandstedt J, Abrahamsson J, Baseckas G, Bobjer J, Gerdtsson A, Gunnlaugsson A, et al.
Scand J Urol . 2023 Apr; 58:4-10. PMID: 37096322
Objective: To report population-based clinical presentation and outcomes in patients with urosymphyseal fistula (USF) after pelvic radiotherapy (RT). Patients And Methods: A retrospective chart review was performed in 33 consecutive...
10.
Ljungquist O, Persmark A, Grabe M, Jakobsen A, Gerdtsson A, Torisson G, et al.
BJU Int . 2022 Feb; 130(4):478-485. PMID: 35174613
No abstract available.